In the present prognostic model, risk groups exhibited well-separated survival curves that reflected the prognosis of good/excellent performance status of metastatic renal-cell carcinoma patients receiving outpatient IL-2/IFN α2a.
The differences of sex-separated Kaplan-Meier survival curves for Mss1 and Mss7 rats compared with their BDIX counterparts also were highly significant (males: Mss1 and Mss7 vs. BDIX, respectively; P = 0,00013 and 0,005, respectively; females: Mss1 and Mss7 vs. BDIX, respectively ; P = 0,000044 and 0,00093, respectively; Figure 2, D and E).
Animals used to evaluate survival rate were from separated group and were not sacrificed until 72 h of observation.
This report was integrated in the HIS in such a way that it can be used by the physicians to view summarized data of their patients in the HIS or to export pseudonymized survival data as comma separated values (CSV).
Using a Kaplan-Meier analysis, we showed that high expression of miR-190b did not impact metastasis-free survival in ER+ and ER- separated subgroups (datas not shown).
Gender-separated analyses were performed and a Kaplan-Meier survival plot graphically illustrates the survival of the sex reassigned cohort and matched controls (all-cause mortality) over time.
The clinical data of 12 cancer types were downloaded from the TCGA_Pancancer page on Synapse (https://www.synapse.org/#!Synapse:syn300013/). Patient survival time was extracted from the tab-separated.patient files and detailed AJCC TNM staging information was merged (e.g., Stage IIA/IIB/IIC was merged as Stage II).
We next investigated the mechanism by which cytokine-treated synovial fibroblasts prolonged neutrophil survival by comparing the ability of FCM and transwell-separated neutrophil synovial cocultures to influence neutrophil survival.
In lung cancer, in contrast, the only therapy that could really be expected to bring any prospect of longer-term survival was (and still is) surgery, following increasingly routinized pathways that separated operable from nonoperable patients.
